CD5024 1% [Ivermectin 1%] Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
Study objectives:
- To compare efficacy and safety of Ivermectin 1% cream versus metronidazole 0.75% cream
in subjects with papulopustular rosacea after 16-week topical treatment.
- And to compare, for subjects initially successfully treated by 16 weeks treatment,
Ivermectin 1 % cream versus metronidazole 0.75% cream during a 36-week extension period
by assessing, the time of first relapse, the relapse rate, and the number of days free
of treatment